.png)
ANTG Gets TGA Listing For Cannabis Strain - HempGazette
<a href="https://news.google.com/rss/articles/CBMiN2h0dHBzOi8vaGVtcGdhemV0dGUuY29tL25ld3MvYW50Zy1hcnRnLWNhbm5hYmlzLWhnMTA1MC_SAQA?oc=5" target="_blank">ANTG Gets TGA Listing For Cannabis Strain</a> <font color="#6f6f6f">HempGazette</font>
Australian Natural Therapeutics Group (ANTG) has listed its cannabis product, EVE Cannabis Indica, on the Australian Register of Therapeutic Goods (ARTG), making it suitable for export. The company, based in New South Wales, aims to improve lives with high-quality medicinal cannabis.
EVE Cannabis Indica is a dried herb with unspecified 140mg/g content. In November, ANTG passed mandatory quality tests (TGO93 and TGO100) for its first commercial export crop. This ARTG listing supports ANTG’s export plans, including a 10-year supply deal with Cannamedical Pharma GmbH in Germany, expecting over two tonnes exported in the first year.
ANTG has three production facilities in Australia and one in California, with plans to expand and produce oils and capsules using supercritical CO2 extraction.
<a href="https://news.google.com/rss/articles/CBMiN2h0dHBzOi8vaGVtcGdhemV0dGUuY29tL25ld3MvYW50Zy1hcnRnLWNhbm5hYmlzLWhnMTA1MC_SAQA?oc=5" target="_blank">ANTG Gets TGA Listing For Cannabis Strain</a> <font color="#6f6f6f">HempGazette</font>
Australian Natural Therapeutics Group (ANTG) has listed its cannabis product, EVE Cannabis Indica, on the Australian Register of Therapeutic Goods (ARTG), making it suitable for export. The company, based in New South Wales, aims to improve lives with high-quality medicinal cannabis.
EVE Cannabis Indica is a dried herb with unspecified 140mg/g content. In November, ANTG passed mandatory quality tests (TGO93 and TGO100) for its first commercial export crop. This ARTG listing supports ANTG’s export plans, including a 10-year supply deal with Cannamedical Pharma GmbH in Germany, expecting over two tonnes exported in the first year.
ANTG has three production facilities in Australia and one in California, with plans to expand and produce oils and capsules using supercritical CO2 extraction.
